title: Re: Adi J. Klil-Drori, Hui Yin, Vicky Tagalakis, Armen Aprikian, Laurent Azoulay. Androgen Deprivation Therapy for Prostate Cancer and Risk of Venous Thromboembolism. Eur Urol 2016;70:56-61.
authors.affiliation: Cancer Epidemiology Group, Division of Cancer Studies, King's College, London, UK; Institue of Environmental Medicine, Karolinska Institute, Stockholm, Sweden. Electronic address: mieke.vanhemelrijck@kcl.ac.uk.
authors.forename: Mieke
authors.initials: M
authors.lastname: Van Hemelrijck
authors.affiliation: Institue of Environmental Medicine, Karolinska Institute, Stockholm, Sweden; Regional Cancer Centre, Akademiska sjukhuset, Uppsala, Sweden.
authors.forename: Hans
authors.initials: H
authors.lastname: Garmo
authors.affiliation: CLINTEC Department, Karolinska Institutet, Stockholm, Sweden.
authors.forename: Jan
authors.initials: J
authors.lastname: Adolfsson
authors.affiliation: Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
authors.forename: Pär
authors.initials: P
authors.lastname: Stattin
mesh_terms: D000726:Androgen Antagonists; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms; D012306:Risk; D054556:Venous Thromboembolism
chemical_list: D000726:Androgen Antagonists